BioSpace News Archive

Viatris Inc. (NASDAQ: VTRS) plans to release its second quarter 2021 financial results on Monday, Aug. 9, before the open of the U.S. financial markets.

Artificial Intelligence (AI) is the potential of the computer-controlled robot or computer to carry out tasks that are usually associated with intelligent beings.

Self-monitoring blood glucose is a modern procedure for diabetes management to check the glucose level instantly and measure the precise capillaries glucose concentration.

Increase in demand for high-purity selective separation, and rising popularity of dialysis procedures over renal transplants have resulted in boosting the medical membranes market.

Increasing cases of neurological disorders, ongoing research activities, and private and government investments.

The rise in the incidence rate of neurological disorders, increasing acceptance of neuro endoscopic surgery over conventional brain surgery have resulted in boosting the Neuroendoscopy market.

The growing incidence of eye diseases and advancements in technology are driving the market for Ophthalmic Devices.

Growing demand for the minimally invasive sugeries using robotic assistance to ascertain the highest precision and succes rate in procedure.

AngioDynamics, Inc., a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, announced that it will host its Investor & Technology Day on Tuesday, July 13, from 9:30 a.m. to approximately 11:30 a.m. ET, which will include a question-and-answer session.

Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) and Beacon Biosignals today announced an extended and expanded strategic partnership between the two companies.